Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Osveral on iron overload in beta thalassemia major patients
IRCT2015102524679N2Phase 3Completed
- Sponsor
- Investigator
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of deferasirox in beta thalassemia major and iron overload, sponsored by Investigator. Started Mar 2015; status: completed.
02
Drugs
deferasirox
03
Conditions
beta thalassemia majoriron overload
Beyond the preview
Go deeper on IRCT2015102524679N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102524679N2.